ALK-Abello A/S
ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. More than 500 million people worldwide have allergies. Many of them suffer in silence because the way ahead is too confusing. By collecting information and the latest and most trusted solutions together in one place, we want to make allergy surprisingly simple to manage. With 100 years of experience, nobody knows allergy like us, and we continuously apply our scientific knowledge and expertise to help people take control of their allergy and their life. We want to make a difference by offering solutions for everyone who is touched by allergy – through a comprehensive range of products, services and resources that offer a fast-track to a more balanced life.
Company details
Find locations served, office locations
- Business Type:
- Service provider
- Industry Type:
- Clinical Services
- Market Focus:
- Globally (various continents)
About Us
Decades of pushing boundaries and raising standards have placed us at the forefront of our industry, and in recent years, we have invested heavily in gathering unprecedented clinical evidence in support of the latest generation of allergy treatments – sublingual allergy immunotherapy (SLIT) tablets.
When complete, our SLIT-tablet range will cover five of the most common respiratory allergies in the world – house dust mite, grass, trees from the birch tree family, ragweed and Japanese cedar – for all relevant age groups. Our tablets for house dust mite, grass, ragweed and Japanese cedar allergies are already available in many markets and we are working hard to complete the range as quickly as possible.
In 2018, we launched a sister brand klarify.me – offering a broad range of pre-screened drug-free products and services to help people manage their allergies. The overall aim is to transform ALK into a broader-based allergy company that reaches many more people who live with allergy and asthma, and which captures a greater share of the global allergy market by offering solutions for everyone touched by allergy through a comprehensive range of products, services and resources.
The book about ALK was written in connection with the company's 85th anniversary in 2008.
The purpose of the book is to give the company's surroundings - current and future employees and its subsidiaries, affiliates, and society as a whole - a thorough understanding of the ALK's history. The book's main author, Professor, Dr. Phil . Kurt Jacobsen from Copenhagen Business School, was given free access to all archives by the company's management.
The book can be freely downloaded, copied and distributed.
Sustainable business
ALK has a long-standing commitment to act responsibly. For more than 10 years, it has been guided by the United Nations’ Global Compact principles, and in 2019, the company affirmed its commitment to these by becoming an active signatory of the UN Global Compact.
This commitment was more directly linked to our business in 2019 when we unveiled a new framework for CSR at ALK, which is more directly linked to our business activities.
- We promise to build upon our heritage as a pioneer in allergy immunotherapy and bring allergy products and solutions to as many people with allergy as possible around the world. We promise to be a workplace characterised by a caring and creative nature where development, diversity, safety and work-life balance are seen as valuable assets. We call it The Human Organisation.
- We promise to take care of the planet by taking actions that benefit the environment and the climate. We want to set ambitious goals that bring positive changes to the planet.
n addition, we are contributing to the UN 2030 Agenda for Sustainable Development and have pledged our support for the UN Sustainable Development Goals.
In particular:
- SDG3: Good health and well-being: We contribute to healthy lives and promote well-being for patients and our employees at all ages
- SDG8: Decent work and economic growth: We work systematically to improve the working environment in all parts of our organisation and to promote safety at work
- SDG12: Responsible consumption and production: We support a precautionary approach to environmental challenges and continuously seek to use natural resources efficiently
- SGD16: Peace, justice and strong institutions: We work to reduce corruption and bribery in all its forms
To set the right targets and support our sustainability strategy further, we conducted a materiality assessment in 2020 to identify those aspects with the highest impact on our business and stakeholders.
The assessment was based on a business analysis as well as input from relevant internal and external stakeholders, and it now forms the basis for target-setting and the prioritisation of resources.